Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Yulia V Gerasimova

Yulia V Gerasimova

University of Central Florida, USA

Title: Split deoxyribozyme sensors for highly selective analysis of nucleic acids

Biography

Biography: Yulia V Gerasimova

Abstract

Deoxyribozymes (Dz) are small catalytic DNA molecules, which can catalyze a variety of chemical reactions. Due to their structural versatility, biocompatibility, signal amplification ability and relatively low cost, Dz are widely used as scaffolds for biosensor design. Here we present a split Dz (sDz) approach for nucleic acid sensors: a Dz is divided into two subunits, which are not catalytically active in the absence of a nucleic acid target due to spatial separation; when target is present, the two subunits are brought in proximity, and the catalytic core is re-formed. As a result, target-inducable signal is generated and can be monitored for target detection and quantification. The binary design enables great selectivity because each of the two short probe-analyte hybrids is very sensitive to even a slight imperfection in the sequence of the analyzed nucleic acid. Using this approach, we have designed sDz sensors targeting rRNA of Escherichia coli, Mycobacterium tuberculosis and M. absesses, which are important human pathogens. We have demonstrated that the sensors are capable of differentiation between single nucleotide substitutions (SNSs) in the analyzed sequences. Therefore, it is possible to use sDz for SNSs and strain genotyping, as well as for drug susceptibility testing of bacterial pathogens. sDz sensors can be also employed for rRNA maturation monitoring and mutation analysis. The sensors can generate either fluorescent signal or color change. In their later implementation, sDz sensors can be used for point-of-care diagnostics of bacterial pathogens. The work was partially supported by NIH R21 HG004060 and NIAID R15AI10388001A1.